New hope for stubborn bipolar depression? epilepsy drug enters major trial
NCT ID NCT07412132
Summary
This study is testing whether adding the medication lacosamide to standard treatments helps people with bipolar disorder who are experiencing a depressive episode that hasn't improved with other medications. Forty adults whose depression hasn't responded to at least two prior treatments will take either lacosamide or a placebo pill for 12 weeks, without knowing which one they receive. Researchers will measure changes in depression symptoms to see if lacosamide works better than the placebo.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BIPOLAR AFFECTIVE DISORDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Instituto de Psiquiatia (IPQ)
RECRUITINGSão Paulo, São Paulo, Brazil
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.